CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$6,13
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$6,06mínimo 52 semanas
$20,56máximo 52 semanas
Capitalización Bursátil (MRQ)
$114M
P/E
-1.0
BPA
$-5.90
tus insignias
Rango 52S
$6–$21
Calificación del Analista
BUY
Precio Objetivo
$34
P/E
-1.0
ROE
-60.8%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
CRBP Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$6.13
Capitalización Bursátil (MRQ)
$114M
P/E
-1.0
BPA
$-5.90
ROE
-60.8%
Rango 52S
$6–$21
CRBP Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 14 de febrero de 2023 | 1-for-30 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos·2016-12-31 → 2022-12-31
BPA$-5.902021-12-31 → 2025-12-31
Flujo de caja libre$-64M2016-12-31 → 2025-12-31
Margen neto·2016-12-31 → 2021-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | CRBP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -1.0promedio 5A ≈-1.4 | ≈-1.4 | · | · | |
| P/C (MRQ) | 1.1promedio 5A ≈9.0 | ≈9.0 | 1.9 | Infravalorado | |
| Price / FCF (Precio / FCF) | -1.7promedio 5A ≈-16.9 | ≈-16.9 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -1.7promedio 5A ≈-13.5 | ≈-13.5 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.7promedio 5A ≈9.0 | ≈9.0 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | CRBP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -48.5%promedio 5A ≈-46.1% | ≈-46.1% | -63.2% | De primer nivel | |
| ROE | -60.8%promedio 5A ≈-65.9% | ≈-65.9% | -108.3% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | CRBP | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 5.7promedio 5A ≈7.9 | ≈7.9 | 5.4 | En línea | |
| Quick Ratio (Ratio Rápido) | 7.9promedio 5A ≈7.7 | ≈7.7 | 4.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-4.4%
Próximo informe
Nov 10, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 3, 2026 | $-1.81 | $-1.28 | -41.1% |
| 31 de marzo de 2026 | $-1.23 | $-1.24 | 1.2% | |
| 31 de diciembre de 2025 | $-1.25 | $-1.61 | 22.2% | |
| 30 de septiembre de 2025 | $-1.90 | $-1.74 | -9.1% | |
| 30 de junio de 2025 | $-1.44 | $-1.54 | 6.6% | |
| 31 de marzo de 2025 | $-1.39 | $-1.31 | -6.5% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $881.7K | $4M | $36M | $5M | $2M | $2M | $648.4K | |
| R&D Expense | $70M | $32M | $31M | $16M | $36M | $98M | $90M | $49M | $26M | $15M | $6M | |
| SG&A Expense | $15M | $16M | $14M | $19M | $20M | $28M | $24M | $13M | $9M | $6M | $4M | |
| Operating Expenses | $85M | $49M | $45M | $40M | $57M | $127M | $113M | $62M | $35M | $22M | $10M | |
| Operating Income | $-85M | $-49M | $-45M | $-40M | $-56M | $-123M | $-77M | $-57M | $-33M | $-20M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $2.4K | |
| Interest Income | · | · | · | · | · | · | $1M | $982.8K | · | · | $3.4K | |
| Other Non-op | $1M | $4M | $3M | $-48.8K | $12M | $13M | $6M | $1M | $141.2K | $-13.6K | $3.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Income | $-79M | $-40M | $-45M | $-42M | $-46M | $-111M | $-71M | $-56M | $-32M | $-20M | $-9M | |
| EPS (Basic) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | $-1.42 | · | · | · | · | · | |
| EPS (Diluted) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | · | · | · | · | · | · | |
| Shares (Basic) | 13,317,116 | 10,915,413 | 4,327,568 | 4,170,675 | 4,094,935 | 78,133,289 | · | · | · | · | · | |
| Shares (Diluted) | 13,317,116 | 10,915,413 | 4,327,568 | 4,170,675 | 4,094,935 | · | · | · | · | · | · | |
| EBITDA | $-85M | $-49M | · | $-40M | $-56M | $-123M | $-77M | $-57M | $-33M | $-20M | $-9M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28M | $17M | $14M | $17M | $25M | $85M | $32M | $42M | $63M | $15M | $12M | |
| Short-term Investments | $135M | $132M | $7M | $42M | $73M | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $4M | $2M | $791.6K | $2M | $4M | $4M | $2M | $3M | $930.3K | $376.5K | |
| Current Assets | $167M | $153M | $24M | $60M | $100M | $92M | $38M | $44M | $66M | $17M | $13M | |
| PP&E (Net) | $159.0K | $385.0K | $973.0K | $2M | $2M | $4M | $5M | $3M | $1M | $435.3K | $124.1K | |
| PP&E (Gross) | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $3M | $2M | $543.5K | $178.5K | |
| Accum. Depreciation | $4M | $4M | $4M | $3M | $2M | $2M | $1M | $666.6K | $363.9K | $108.2K | $54.3K | |
| Other Non-current Assets | · | $0 | $212.0K | $155.3K | $46.4K | $234.0K | $85.0K | $43.8K | $40.8K | · | · | |
| Total Assets | $168M | $156M | $28M | $66M | $108M | $102M | $49M | $47M | $67M | $18M | $13M | |
| Accounts Payable | $2M | $5M | $3M | $2M | $2M | $7M | $11M | $6M | $3M | $3M | $1M | |
| Accrued Liabilities | $17M | $5M | $11M | $6M | $10M | $22M | $22M | $10M | $5M | $3M | $562.3K | |
| Short-term Debt | · | $0 | $301.0K | $353.3K | $767.9K | $710.2K | $752.7K | $394.3K | $332.9K | $271.8K | $162.0K | |
| Current Liabilities | $21M | $12M | $32M | $13M | $17M | $32M | $35M | $18M | $8M | $9M | $4M | |
| Capital Leases | $0 | $2M | $3M | $5M | $6M | $7M | $8M | · | · | · | · | |
| Other Non-current Liabilities | · | $0 | $44.0K | $22.2K | $22.2K | · | · | · | $375 | $4.6K | · | |
| Total Liabilities | $21M | $13M | $35M | $33M | $39M | $57M | $43M | $19M | $9M | $9M | $4M | |
| Long-term Debt | · | · | $18M | $22M | $21M | $21M | · | · | · | · | · | |
| Total Debt | · | $0 | · | $19M | $19M | $19M | $752.7K | $394.3K | $332.9K | $271.8K | $162.0K | |
| Common Stock | $2.0K | $1.0K | $0 | $417 | $416 | $9.9K | $6.5K | $5.7K | $5.6K | $4.5K | $3.8K | |
| Paid-in Capital | $703M | $619M | $430M | $425M | $419M | $349M | $199M | $149M | · | · | · | |
| Retained Earnings | $-555M | $-477M | $-437M | $-392M | $-350M | $-304M | $-193M | $-121M | $-66M | $-33M | $-13M | |
| AOCI | $-53.0K | $35.0K | $-1.0K | $-126.1K | $-62.4K | · | · | · | · | · | · | |
| Stockholders' Equity | $148M | $142M | $-7M | $33M | $69M | $45M | $6M | $28M | $58M | $9M | $9M | |
| Liabilities + Equity | $168M | $156M | $28M | $66M | $108M | $102M | $49M | $47M | $67M | $18M | $13M | |
| Shares Outstanding | 17,611,511 | 12,179,482 | 4,423,683 | 4,171,297 | 4,169,631 | 98,852,696 | 64,672,893 | 57,247,496 | 55,603,427 | 44,681,745 | 37,605,134 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $233.0K | $588.0K | $641.0K | $763.0K | $999.8K | $1M | $739.4K | $493.9K | $255.7K | $87.7K | $43.9K | |
| Stock-based Comp | $6M | $6M | $3M | $6M | $9M | $12M | $12M | $8M | $6M | $3M | $1M | |
| Operating Cash Flow | $-64M | $-42M | $-36M | $-38M | $-48M | $-100M | $-46M | $-30M | $-28M | $-14M | $-5M | |
| CapEx | $7.0K | $0 | $0 | $13.4K | $54.2K | $484.5K | $3M | $2M | $707.4K | $353.0K | $114.0K | |
| Investing Cash Flow | $-2M | $-121M | $36M | $30M | $-73M | $-484.5K | $-3M | $-2M | $-707.4K | · | · | |
| Debt Issued | · | · | · | $1M | · | $19M | · | · | · | · | · | |
| Net Debt Issued | · | · | · | $1M | · | $19M | · | · | · | · | · | |
| Stock Issued | $77M | $182M | $53.0K | · | $63M | $142M | $41M | $12M | $79M | $17M | $11M | |
| Net Stock Activity | $77M | $182M | · | · | $63M | $142M | $41M | $12M | $79M | $17M | $11M | |
| Financing Cash Flow | $77M | $167M | $-3M | $-533.6K | $61M | $155M | $38M | $11M | $76M | · | · | |
| Net Change in Cash | $11M | $3M | $-3M | $-8M | $-61M | $55M | $-10M | $-21M | $48M | · | $6M | |
| Free Cash Flow | $-64M | · | · | $-38M | $-48M | $-100M | $-48M | $-32M | $-29M | $-14M | $-5M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -6350.1% | -3119.2% | -213.3% | -1176.8% | -1334.4% | -1045.6% | -1365.5% | |
| Net Margin | · | · | · | · | -5176.4% | -2826.1% | -197.7% | -1154.5% | -1328.7% | -1046.3% | -1365.0% | |
| EBITDA Margin | · | · | · | · | -6350.1% | -3119.2% | -213.3% | -1176.8% | -1334.4% | -1045.6% | -1365.5% | |
| ROA | -48.5% | -43.7% | · | -48.7% | -43.5% | -146.9% | -148.7% | -97.7% | -76.4% | -130.0% | -90.9% | |
| ROE | -60.8% | -27.5% | · | -113.0% | -62.2% | -298.7% | -399.2% | -158.2% | -97.2% | -223.4% | -119.2% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.1 | 12.9 | · | 4.8 | 5.9 | 2.9 | 1.1 | 2.4 | 8.0 | 2.0 | 3.5 | |
| Quick Ratio | 7.9 | 12.6 | · | 4.7 | 5.7 | 2.7 | 0.9 | 2.3 | 7.6 | 1.7 | 3.4 | |
| Debt / Equity | · | 0.0 | · | 0.6 | 0.3 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| LT Debt / Equity | · | · | · | 0.5 | 0.2 | 0.4 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -3628.6 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.1 | 0.8 | 0.1 | 0.1 | 0.1 | 0.1 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.38 | $11.69 | · | $7.91 | $0.55 | $0.46 | $0.10 | $0.48 | $1.04 | $0.20 | $0.24 | |
| Revenue / Share | · | · | · | $0.00 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-4.84 | $-3.83 | · | $-9.00 | · | · | · | · | · | · | · | |
| Cash / Share | $1.62 | $1.41 | · | $4.08 | $0.20 | $0.86 | $0.49 | $0.73 | $1.12 | $0.34 | $0.33 | |
| EPS (TTM) | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 | · | · | · | · | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | -77.6% | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $0 | $881.7K | $4M | $36M | $5M | $2M | $2M | $648.4K | |
| Net Income TTM | $-79M | $-40M | $-45M | $-42M | $-46M | $-111M | $-71M | $-56M | $-32M | $-20M | $-9M | |
| Market Cap | $143M | $144M | · | $14M | $2.31B | $3.71B | $10.59B | $10.03B | $11.84B | $11.33B | $1.86B | |
| Enterprise Value | · | $-5M | · | $-26M | $2.24B | $3.64B | $10.56B | $9.99B | $11.78B | $11.31B | $1.85B | |
| P/E | -1.4 | -3.2 | -0.6 | -0.3 | -1.7 | · | · | · | · | · | · | |
| P/S | · | · | · | · | 2624.8 | 941.5 | 293.1 | 2079.9 | 4853.5 | 5925.9 | 2870.9 | |
| P/B | 1.0 | 1.0 | · | 0.4 | 33.5 | 81.9 | 1720.4 | 364.4 | 205.0 | 1269.9 | 207.2 | |
| P / Tangible Book | 1.0 | 1.0 | · | 0.4 | 33.5 | 81.9 | · | · | · | · | · | |
| P / Cash Flow | -2.2 | -3.4 | · | -0.4 | -48.0 | -37.2 | -231.7 | -333.6 | -426.1 | -834.6 | -400.5 | |
| P / FCF | -2.2 | · | · | -0.4 | -48.0 | -37.0 | -218.6 | -309.9 | -415.5 | -813.5 | -390.9 | |
| EV / EBITDA | · | 0.1 | · | 0.7 | -39.9 | -29.6 | -137.0 | -176.0 | -361.8 | -566.0 | -208.9 | |
| EV / FCF | · | · | · | 0.7 | -46.4 | -36.3 | -217.9 | -308.6 | -413.3 | -812.4 | -388.4 | |
| EV / Revenue | · | · | · | · | 2536.1 | 924.6 | 292.2 | 2071.3 | 4828.0 | 5918.2 | 2852.1 | |
| Earnings Yield | -72.5% | -31.2% | -170.7% | -304.8% | -60.3% | · | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| R&D Expense | $31M | $20M | $18M | $21M | $15M | $16M | $9M | $11M | $7M | $6M | $7M | $7M | $4M | $13M | $6M | $4M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $4M | $3M | $3M | $4M | $4M | $5M | $4M | |
| Operating Expenses | $36M | $24M | $22M | $24M | $19M | $20M | $13M | $16M | $11M | $10M | $10M | $9M | $8M | $17M | $11M | $8M | |
| Operating Income | $-36M | $-24M | $-22M | $-24M | $-19M | $-20M | $-13M | $-16M | $-11M | $-10M | $-10M | $-9M | $-8M | $-17M | $-11M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $652.0K | · | · | · | $1M | · | · | · | |
| Other Non-op | $-11.0K | $-67.0K | $1.0K | $-50.0K | $176.0K | $1M | $1M | $200.0K | $43.0K | $3M | $2M | $218.0K | $183.0K | $229.5K | $275.5K | $77.7K | |
| Net Income | $-35M | $-23M | $-21M | $-23M | $-18M | $-17M | $-10M | $-14M | $-10M | $-7M | $-8M | $-10M | $-9M | $-18M | $-11M | $-9M | |
| EPS (Basic) | $-1.81 | $-1.23 | $-1.17 | $-1.90 | $-1.44 | $-1.39 | $-0.80 | $-1.15 | $-0.90 | $-0.83 | $-1.75 | $-2.27 | $-2.05 | $-4.24 | $-2.60 | $-2.11 | |
| EPS (Diluted) | $-1.81 | $-1.23 | $-1.17 | $-1.90 | $-1.44 | $-1.39 | $-0.80 | $-1.15 | $-0.90 | $-0.83 | $-1.75 | $-2.27 | $-2.05 | $-4.24 | $-2.60 | $-2.11 | |
| Shares (Basic) | 19,407,688 | 18,706,622 | · | 12,307,298 | 12,240,443 | 12,202,092 | · | 12,014,700 | 11,053,241 | 8,310,508 | · | 4,423,617 | 4,277,701 | 4,181,556 | · | 4,170,881 | |
| Shares (Diluted) | 19,407,688 | 18,706,622 | · | 12,307,298 | 12,240,443 | 12,202,092 | · | 12,014,700 | 11,053,241 | 8,310,508 | · | 4,423,617 | 4,277,701 | 4,181,556 | · | 4,170,881 | |
| EBITDA | $-36M | $-24M | · | $-24M | $-19M | $-20M | · | $-16M | $-11M | $-10M | · | $-9M | $-8M | $-17M | · | $-8M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $26M | $28M | $27M | $20M | $19M | $17M | $19M | $24M | $14M | $14M | $11M | $8M | $7M | $17M | $12M | |
| Short-term Investments | $95M | $113M | $135M | $77M | $97M | $114M | $132M | $140M | $123M | $106M | $7M | $17M | $28M | $37M | $42M | $54M | |
| Prepaid Expense | $5M | $5M | $3M | $3M | $6M | $4M | $4M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $791.6K | $926.2K | |
| Current Assets | $123M | $144M | $167M | $108M | $123M | $137M | $153M | $161M | $148M | $122M | $24M | $31M | $38M | $46M | $60M | $67M | |
| PP&E (Net) | $71.0K | $116.0K | $159.0K | $201.0K | $251.0K | $304.0K | $385.0K | $519.0K | $671.0K | $821.5K | $973.0K | $1M | $1M | $1M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $0 | $0 | $0 | $212.0K | $201.3K | $211.9K | $182.4K | $155.3K | $133.1K | |
| Total Assets | $127M | $144M | $168M | $110M | $125M | $140M | $156M | $164M | $152M | $126M | $28M | $36M | $44M | $52M | $66M | $74M | |
| Accounts Payable | $5M | $435.0K | $2M | $3M | $4M | $4M | $5M | $3M | $1M | $2M | $3M | $5M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | $15M | $16M | $17M | $13M | $8M | $6M | $5M | $7M | $10M | $9M | $11M | $8M | $6M | $6M | $6M | $5M | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $77.0K | $189.8K | $301.0K | $0 | $51.2K | $203.3K | $353.3K | $0 | |
| Current Liabilities | $21M | $18M | $21M | $17M | $13M | $12M | $12M | $12M | $24M | $26M | $32M | $32M | $16M | $14M | $13M | $17M | |
| Capital Leases | $3M | · | $0 | $307.0K | $761.0K | $1M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $0 | $44.0K | $44.4K | $22.2K | $3M | $22.2K | $22.2K | |
| Total Liabilities | $25M | $18M | $21M | $17M | $14M | $13M | $13M | $14M | $26M | $29M | $35M | $36M | $34M | $35M | $33M | $32M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $13M | · | $20M | $21M | $22M | $19M | $21M | |
| Total Debt | · | · | · | · | · | · | · | $0 | $77.0K | $13M | · | $18M | $18M | $19M | · | $19M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.1K | $0 | $442 | $442 | $422 | $417 | $12.5K | |
| Paid-in Capital | $716M | $705M | $703M | $627M | $623M | $621M | $619M | $618M | $580M | $541M | $430M | $429M | $428M | $426M | $425M | $423M | |
| Retained Earnings | $-613M | $-578M | $-555M | $-535M | $-512M | $-494M | $-477M | $-467M | $-454M | $-444M | $-437M | $-429M | $-419M | $-410M | $-392M | $-381M | |
| AOCI | $-107.0K | $-161.0K | $-53.0K | $-3.0K | $-39.0K | $-23.0K | $35.0K | $207.0K | $-388.0K | $-328.5K | $-1.0K | $-8.0K | $-23.8K | $-68.5K | $-126.1K | $-206.9K | |
| Stockholders' Equity | $102M | $126M | $148M | $92M | $111M | $127M | $142M | $150M | $126M | $97M | $-7M | $311.0K | $10M | $16M | $33M | $42M | |
| Liabilities + Equity | $127M | $144M | $168M | $110M | $125M | $140M | $156M | $164M | $152M | $126M | $28M | $36M | $44M | $52M | $66M | $74M | |
| Shares Outstanding | 18,671,498 | 17,738,870 | 17,611,511 | 12,534,853 | 12,254,069 | 12,232,853 | 12,179,482 | 12,179,482 | 11,498,917 | 10,507,237 | 4,423,683 | 4,423,683 | 4,422,741 | 4,215,133 | 4,171,297 | 125,280,881 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $51.0K | $49.0K | $49.0K | $50.0K | $53.0K | $81.0K | $134.0K | $152.0K | $150.3K | $152.0K | $148.0K | $152.8K | $158.1K | $181.9K | $184.4K | $190.8K | |
| Stock-based Comp | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $982.0K | $799.0K | $821.2K | $823.6K | $1M | $1M | $1M | |
| Operating Cash Flow | $-30M | $-26M | $-16M | $-16M | $-17M | $-16M | $-11M | $-14M | $-9M | $-8M | $-6M | $-7M | $-8M | $-15M | $-7M | $-7M | |
| CapEx | $6.0K | $6.0K | · | · | $0 | $0 | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Investing Cash Flow | $18M | $22M | $-57M | $20M | $18M | $18M | $9M | $-15M | $-16M | $-98M | $10M | $11M | $9M | $6M | $12M | $-6M | |
| Stock Issued | · | · | $75M | $3M | $0 | $0 | $-13.0K | $36M | $31M | $109M | $-74.0K | $-109.6K | $169.9K | $37.1K | · | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $116M | · | · | · | $37.1K | · | · | |
| Financing Cash Flow | · | · | $75M | $3M | $0 | $0 | $-13.0K | $25M | $35M | $107M | $-2M | $-820.7K | $18.0K | $-113.0K | $234.3K | $-110.7K | |
| Net Change in Cash | $-2M | $-3M | $2M | $7M | $1M | $2M | $-2M | $-4M | $10M | $379.0K | $2M | $3M | $1M | $-10M | $5M | $-13M | |
| Free Cash Flow | · | $-26M | · | · | · | · | · | · | · | · | · | · | · | $-15M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -1304.0% | -1212.8% | 5436.1% | · | 1242.9% | 1055.9% | 2551.1% | · | · | |
| Net Margin | · | · | · | · | · | · | · | -1159.2% | -1103.4% | 3897.3% | · | 1317.0% | 1132.5% | 2617.1% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -1304.0% | -1212.8% | 5436.1% | · | 1242.9% | 1055.9% | 2551.1% | · | · | |
| ROA | -27.8% | -16.2% | · | -17.1% | -12.8% | -12.8% | · | -13.8% | -10.2% | -7.8% | · | -18.3% | -14.0% | -24.1% | · | -9.1% | |
| ROE | -32.9% | -18.1% | · | -19.2% | -14.9% | -15.2% | · | -18.3% | -14.8% | -12.2% | · | -47.6% | -29.8% | -45.7% | · | -14.7% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 7.9 | · | 6.3 | 9.2 | 11.8 | · | 13.8 | 6.2 | 4.7 | · | 1.0 | 2.3 | 3.2 | · | 3.9 | |
| Quick Ratio | 5.5 | 7.6 | · | 6.1 | 8.7 | 11.4 | · | 13.7 | 6.1 | 4.6 | · | 0.9 | 2.2 | 3.1 | · | 3.8 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.1 | · | 57.4 | 1.9 | 1.2 | · | 0.5 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | 1.2 | 0.8 | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -16.9 | · | · | · | · | · | · | · |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | -0.0 | · | -0.0 | -0.0 | -0.0 | · | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.48 | $7.12 | · | $7.35 | $9.06 | $10.39 | · | $12.36 | $10.92 | $9.23 | · | $0.07 | $2.15 | $3.90 | · | $0.33 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.10 | $0.08 | $-0.02 | · | $-0.17 | $-0.18 | $-0.16 | · | $0.00 | |
| Cash Flow / Share | · | $-1.37 | · | · | · | $-1.35 | · | · | · | $-0.96 | · | · | · | $-3.61 | · | · | |
| Cash / Share | $1.25 | $1.45 | · | $2.15 | $1.64 | $1.54 | · | $1.59 | $2.06 | $1.34 | · | $2.54 | $1.89 | $1.74 | · | $0.10 | |
| EPS (TTM) | $-6.11 | $-5.74 | · | $-5.53 | $-4.78 | $-4.24 | · | $-4.63 | $-5.75 | $-6.90 | · | $-11.16 | $-11.00 | $-12.13 | · | $-18.41 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-102M | $-85M | · | $-68M | $-58M | $-50M | · | $-39M | $-35M | $-34M | · | $-47M | $-46M | $-51M | · | $-42M | |
| Market Cap | $175M | $167M | · | $159M | $85M | $65M | · | $251M | $520M | $412M | · | $30M | $35M | $31M | · | $620M | |
| Enterprise Value | · | · | · | · | · | · | · | $92M | $373M | $305M | · | $19M | $16M | $6M | · | $573M | |
| P/E | -1.5 | -1.6 | · | -2.3 | -1.4 | -1.3 | · | -4.5 | -7.9 | -5.7 | · | -0.6 | -0.7 | -0.6 | · | -0.3 | |
| P/B | 1.7 | 1.3 | · | 1.7 | 0.8 | 0.5 | · | 1.7 | 4.1 | 4.3 | · | 95.9 | 3.6 | 1.9 | · | 14.8 | |
| P / Tangible Book | 1.7 | 1.3 | · | 1.7 | 0.8 | 0.5 | · | 1.7 | 4.1 | 4.3 | · | 95.9 | 3.6 | 1.9 | · | 14.8 | |
| P / Cash Flow | · | -6.5 | · | · | · | -4.0 | · | · | · | -51.7 | · | · | · | -2.0 | · | · | |
| Earnings Yield | -65.1% | -61.1% | · | -43.7% | -69.3% | -79.8% | · | -22.4% | -12.7% | -17.6% | · | -165.6% | -140.3% | -166.9% | · | -371.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | · | · | · | $0 | $881.7K |
| Margen Operativo % | · | · | · | · | -6350.1% |
| Beneficio neto | $-79M | $-40M | $-45M | $-42M | $-46M |
| EPS Diluido | $-5.90 | $-3.68 | $-10.31 | $-10.15 | $-11.15 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | · | 0.0 | · | 0.6 | 0.3 |
| Ratio corriente | 8.1 | 12.9 | · | 4.8 | 5.9 |
| Ratio Rápido | 7.9 | 12.6 | · | 4.7 | 5.7 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-64M | · | · | $-38M | $-48M |
Propietarios institucionales (13F) 123 declarantes · $154.4M total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
123
Valor en tenencia
$154.4M
Nuevas posiciones
26
Posiciones cerradas
23
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 26 (-7 vs trimestre anterior) | 23 (+11 vs trimestre anterior) | 35 (+1 vs trimestre anterior) | 27 (+5 vs trimestre anterior) | +2.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Cormorant Asset Management, LP | $21 995 828 | 2 344 971 | 14,25% | Acciones |
| ORBIMED ADVISORS LLC | $16 295 752 | 1 737 287 | 10,56% | Acciones |
| BlackRock, Inc. | $12 486 047 | 1 331 135 | 8,09% | Acciones |
| Aberdeen Group plc | $12 398 015 | 1 321 750 | 8,03% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $7 137 617 | 760 940 | 4,62% | Acciones |
| VANGUARD GROUP INC | $6 995 573 | 859 407 | 4,53% | Acciones |
| Jones Hill Capital LP | $6 130 505 | 653 572 | 3,97% | Acciones |
| Prosight Management, LP | $6 097 000 | 650 000 | 3,95% | Acciones |
| DIADEMA PARTNERS LP | $5 945 044 | 633 800 | 3,85% | Opción de compra |
| Caption Management, LLC | $5 368 174 | 572 300 | 3,48% | Opción de compra |
| Stonepine Capital Management, LLC | $3 986 500 | 425 000 | 2,58% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $3 972 122 | 423 374 | 2,57% | Acciones |
| ADAR1 Capital Management, LLC | $3 956 362 | 421 787 | 2,56% | Acciones |
| DIADEMA PARTNERS LP | $2 825 856 | 301 264 | 1,83% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 750 244 | 293 203 | 1,78% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 511 964 | 267 800 | 1,63% | Opción de compra |
| STATE STREET CORP | $2 388 823 | 254 672 | 1,55% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $1 783 533 | 190 214 | 1,16% | Acciones |
| Exome Asset Management LLC | $1 734 493 | 184 914 | 1,12% | Acciones |
| COMERICA BANK | $1 628 008 | 200 001 | 1,05% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1 422 383 | 151 640 | 0,92% | Acciones |
| JANE STREET GROUP, LLC | $1 305 068 | 139 133 | 0,85% | Acciones |
| NORTHERN TRUST CORP | $1 171 618 | 124 906 | 0,76% | Acciones |
| CITADEL ADVISORS LLC | $1 071 196 | 114 200 | 0,69% | Opción de compra |
| VANGUARD FIDUCIARY TRUST CO | $1 054 284 | 112 397 | 0,68% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 044 013 | 111 302 | 0,68% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 039 510 | 110 822 | 0,67% | Acciones |
| DAFNA Capital Management LLC | $1 010 911 | 107 773 | 0,65% | Acciones |
| CITADEL ADVISORS LLC | $864 405 | 92 154 | 0,56% | Acciones |
| Advisory Services Network, LLC | $843 740 | 89 951 | 0,55% | Acciones |
| MARSHALL WACE, LLP | $744 125 | 79 331 | 0,48% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $732 766 | 78 120 | 0,47% | Acciones |
| Persistent Asset Partners Ltd | $721 500 | 76 919 | 0,47% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $712 683 | 75 979 | 0,46% | Acciones |
| XTX Topco Ltd | $634 595 | 67 654 | 0,41% | Acciones |
| Verdad Advisers, LP | $596 596 | 63 603 | 0,39% | Acciones |
| GOLDMAN SACHS GROUP INC | $589 655 | 62 863 | 0,38% | Acciones |
| ADAR1 Capital Management, LLC | $562 800 | 60 000 | 0,36% | Opción de compra |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $520 168 | 55 455 | 0,34% | Acciones |
| DOLIVER ADVISORS, LP | $518 149 | 75 975 | 0,34% | Acciones |
| HSBC HOLDINGS PLC | $504 747 | 55 224 | 0,33% | Acciones |
| UBS Group AG | $457 716 | 48 797 | 0,30% | Acciones |
| Bank of New York Mellon Corp | $424 746 | 45 282 | 0,28% | Acciones |
| Rangeley Capital, LLC | $412 720 | 44 000 | 0,27% | Acciones |
| CANTOR FITZGERALD, L. P. | $376 117 | 40 098 | 0,24% | Acciones |
| Driehaus Capital Management LLC | $365 604 | 38 977 | 0,24% | Acciones |
| LMR Partners LLP | $332 990 | 35 500 | 0,22% | Acciones |
| Engineers Gate Manager LP | $279 524 | 29 800 | 0,18% | Acciones |
| Caption Management, LLC | $261 252 | 27 852 | 0,17% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $250 446 | 26 700 | 0,16% | Opción de venta |
Informantes de la empresa 25 insiders · 7 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Mark Tepper | President and CSO | 18 de enero de 2019 A | 2 110 400 | 0 | 0 | $0 |
| Ian Hodgson | Chief Operating Officer | 17 de febrero de 2026 S | 51 080 | 0 | 2 | $-25 788 |
| Craig Stuart Millian | Chief Operating Officer | 13 de febrero de 2023 A | 27 000 | 0 | 0 | $0 |
| Robert Paul Discordia | Chief Operating Officer | 17 de marzo de 2020 P | 35 490 | 0 | 0 | $0 |
| Dominic Smethurst | Chief Medical Officer | 2 de marzo de 2026 S | 89 790 | 0 | 2 | $-77 181 |
| Rachael Louise Brake | Chief Scientific Officer | 13 de febrero de 2023 A | · | 0 | 0 | $0 |
| Barbara White | Chief Medical Officer | 2 de febrero de 2021 A | 206 217 | 0 | 0 | $0 |
| Yong Ben | Consejero | 14 de septiembre de 2026 S | 9 383 | 0 | 1 | $-15 680 |
| Anne Altmeyer | Consejero | 10 de junio de 2026 S | 7 579 | 0 | 2 | $-40 809 |
| John Kenneth Jenkins | Consejero | 10 de junio de 2026 S | 3 833 | 0 | 1 | $-37 968 |
| Winston Kung | Consejero | 10 de junio de 2026 S | 12 140 | 0 | 1 | $-16 026 |
| Brent Pfeiffenberger | Consejero | 19 de mayo de 2026 A | 7 500 | 0 | 0 | $0 |
| Rachelle Suzanne Jacques | Consejero | 19 de mayo de 2026 A | 11 383 | 0 | 0 | $0 |
| Alan F Holmer | Consejero | 30 de mayo de 2025 A | 10 629 | 0 | 0 | $0 |
| Peter Salzmann | Consejero | 30 de mayo de 2024 A | 2 783 | 0 | 0 | $0 |
| Avery W Catlin | Consejero | 30 de mayo de 2024 A | 4 350 | 0 | 0 | $0 |
| George Golumbeski | Consejero | 6 de julio de 2020 A | · | 0 | 0 | $0 |
| David P Hochman | Consejero | 20 de mayo de 2020 A | 7 000 | 0 | 0 | $0 |
| Paris Panayiotopoulos | Consejero | 22 de mayo de 2019 A | 14 285 | 0 | 0 | $0 |
| Renu Gupta | Consejero | 25 de mayo de 2017 A | 15 000 | 0 | 0 | $0 |
| Leonardo Viana Nicacio | · | 16 de agosto de 2026 A | 58 333 | 0 | 0 | $0 |
| Nishant C Saxena | · | 11 de agosto de 2026 P | 77 900 | 3 | 0 | $126 243 |
| Yuval Cohen | · | 7 de agosto de 2026 S | 157 316 | 0 | 4 | $-750 480 |
| Sean F. Moran | · | 7 de agosto de 2026 S | 84 694 | 0 | 3 | $-378 471 |
| Sumner Burstein | · | 16 de noviembre de 2015 G | 3 594 471 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 14 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,03% | 56 554 SH | 11 de septiembre de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 14 313 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 7 862 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 421 328 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 58 383 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1 791 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 201 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 2 680 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 4 229 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 208 310 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 533 575 SH | 19 de agosto de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 95 158 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 1 831 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 156 222 SH | 11 de septiembre de 2026 | Diario |
CRBP Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 16 analistas
COMPRA
Objetivo mediano
$34.00
+454,6%
7 43,8%
Compra fuerte
8 50,0%
Compra
1 6,2%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
10 analistas · 2026-09-30Objetivo medio $34.02 +455,1%
← Por Debajo de Todos los Objetivos
Precio Actual $6.13
Mín$17.25
Media$34.02
Máx$48.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| CRBP | $143M | -1.4 | · | · | -60.8% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| INO | $120M | -1.0 | -70.0% | -130000.0% | -322.8% | · |
| HURA | · | -1.2 | · | · | · | · |
| VTVT | · | · | · | · | -70.4% | · |
| UNCY | $128M | -3.5 | -29.0% | · | -113.9% | · |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| GNLX | $166M | -5.1 | 0.00% | -401812.5% | -181.4% | · |
| XGN | $139M | -6.5 | 19.7% | -30.0% | -103.7% | 58.3% |
| COYA | $121M | -4.6 | 123.6% | -267.1% | -59.5% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026